SSKN
STRATA Skin Sciences, Inc.NASDAQHealthcareAs of 2026-04-04
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.37
P/S
0.03
EV/EBITDA
-16.34
DCF Value
$-1.09
FCF Yield
-495.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
57.8%
Operating Margin
-19.7%
Net Margin
-21.1%
ROE
-360.3%
ROA
-21.2%
ROIC
-31.7%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $9.3M | $58.0K | $0.01 |
| FY 2025 | $30.7M | $-6.3M | $-1.35 |
| Q3 2025 | $6.9M | $-1.6M | $-0.36 |
| Q2 2025 | $7.7M | $-2.5M | $-0.60 |
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.47
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.